Boussard & Gavaudan Investment Management’s DICE Therapeutics, Inc. Common Stock DICE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q3
Sell
-1,072
Closed -$4.08K 133
2023
Q2
$4.08K Buy
+1,072
New +$37.1K ﹤0.01% 115